| FIELD OF APPLICATION | DETAILS |
|---|---|
| Generic Name | Naftazone |
| Active Ingredient | Naftazone |
| Brand Names | Mediaven, Mediavene |
| Drug Category | Cardiology |
| Drug Class | Palliative treatment, Immunosuppressive therapy |
| Route of Administration | Oral |
| FDA Approval Status | Not Approved |
Naftazone Overview
Naftazone is a specialized veno-active medication belonging to the naphthalenes class of organic compounds. Within the Cardiology and phlebology fields, it is utilized as a capillary stabilizing agent to manage conditions caused by poor venous blood flow, such as varicose veins and hemorrhoids.
What Is Naftazone & How Does It Work
Naftazone acts as a Targeted Therapy for venous and microcirculatory disorders. In healthy individuals, veins rely on one-way valves and elastic walls to pump blood back to the heart. In conditions like chronic venous insufficiency, these valves fail and the vessel walls stretch, leading to blood pooling, inflammation, and capillary leakage.
Naftazone functions through a multifaceted mechanism to protect vascular endothelial cells and stabilize capillary walls:
- Hyaluronic Acid Preservation: It inhibits the degradation of hyaluronic acid, a key structural component of the capillary extracellular matrix, thereby reducing vessel fragility and preventing fluid leakage into surrounding tissues.
- Enzyme Modulation: The drug inhibits elastase, an enzyme that breaks down elastin, ensuring the blood vessels maintain their natural elasticity and resilience.
- Anti-inflammatory Action: Naftazone reduces the adhesion and activation of white blood cells (leukocytes) along the inner lining of the blood vessels, suppressing the inflammatory cascade that exacerbates venous disease.
- Microcirculatory Improvement: By reducing blood viscosity and inhibiting excessive platelet clumping, it enhances overall microcirculation and ensures better oxygen delivery to compromised tissues.
Is Naftazone FDA Approved
Naftazone has not been approved by the FDA. However, it holds a long history of regulatory approval and clinical use in several European and international markets, where it is commonly prescribed for the management of venous and capillary dysfunction.
What Is Naftazone Used For
- The symptomatic treatment of chronic venous insufficiency (CVI), reducing leg heaviness, swelling (edema), and pain.
- The management of hemorrhoids, helping to reduce localized venous inflammation and bleeding.
- Supportive therapy for superficial thrombophlebitis and the treatment of painful varicose veins.
Before Taking Naftazone: Contraindications & Precautions
While generally considered a safe vasoprotective agent in regions where it is approved, patients must be evaluated for underlying conditions that could complicate venous therapy.
Who Should Not Take Naftazone
- Patients with a known severe hypersensitivity or allergic reaction to naphthoquinone derivatives or any inactive ingredients in the tablet.
- Individuals with severe hepatic (liver) or renal (kidney) impairment, as compromised organ function may alter the clearance of the drug from the bloodstream.
Naftazone Pregnancy and Fertility
- Clinical data regarding the safety of Naftazone during pregnancy is highly limited. It is generally recommended to avoid use during pregnancy unless a physician determines the potential benefits heavily outweigh the theoretical risks.
- Nursing mothers are typically advised to avoid taking the medication, as it is unknown whether the active compound or its metabolites are excreted into human breast milk.
Tell Your Doctor Before Taking Naftazone
- Disclose any history of severe bleeding disorders or concurrent use of blood-thinning medications, as Naftazone can subtly influence platelet aggregation and blood rheology.
- Provide a complete list of all current medications, particularly other blood pressure drugs or vasoactive agents, to avoid unintended overlapping effects on vascular tone.
Naftazone: Dosage & Administration
Where approved internationally, Naftazone is typically integrated into a broader management plan that includes compression therapy and lifestyle modifications.
Standard Naftazone Dosing
- Oral dosages for chronic venous insufficiency generally involve taking a standard 10 mg or 30 mg tablet divided throughout the day, depending on the specific international formulation and the severity of the venous pooling.
- For acute hemorrhoidal flare-ups, physicians may prescribe a higher short-term induction dose, subsequently tapering down to a standard maintenance dose once the acute inflammation subsides.
How Naftazone Is Administered
- The oral tablets should be swallowed whole with a glass of water.
- It is often recommended to take the medication during or immediately after meals to maximize gastrointestinal tolerability.
- Patients may not experience immediate relief; consistent daily dosing over several weeks is often required to achieve significant improvements in vascular tone and reduced edema.
Naftazone: Clinical Efficacy & Research
Clinical observations in international markets demonstrate that Naftazone effectively improves symptoms of venous stasis. By simultaneously targeting the structural integrity of the capillary walls and the inflammatory response inside the vessel, it provides comprehensive vasoprotection. Furthermore, preclinical research has explored its unique ability to inhibit glutamate release, indicating potential but unapproved applications in neurodegenerative conditions like Parkinson’s disease. However, its primary established efficacy remains firmly within the realm of treating varicose veins and chronic venous disease.
Naftazone: Side Effects & Safety Profile
As a medication that is not approved locally, Naftazone does not carry a standard commercial Boxed Warning. International prescribing information generally classifies it as a low-risk capillary stabilizing agent.
Naftazone is generally well-tolerated, with a side effect profile characteristic of oral venotonic agents.
Naftazone Common Side Effects
- Mild gastrointestinal disturbances, including nausea, stomach upset, or indigestion.
- Occasional mild headaches.
- Temporary skin rashes or mild allergic skin reactions (erythema).
Serious Naftazone Adverse Events
- Though extremely rare, severe hypersensitivity reactions (anaphylaxis) presenting with facial swelling and breathing difficulties can occur.
- Unexplained, spontaneous bruising or minor bleeding if the drug’s mild platelet-inhibiting properties interact unfavorably with underlying hematologic conditions.
Managing Naftazone Side Effects
Routine gastrointestinal side effects are typically managed easily by ensuring the medication is taken alongside food. If a patient develops a persistent skin rash or signs of a severe allergic reaction, the medication must be discontinued immediately, and alternative veno-active therapies (such as flavonoids) should be considered.
Naftazone: Interactions & What to Avoid
Because Naftazone acts on the microcirculation, combining it with other systemic cardiovascular drugs requires basic clinical awareness.
Naftazone Interactions
- Co-administration with potent anticoagulants (like warfarin) or antiplatelet drugs (like aspirin) may theoretically increase the risk of minor bleeding, given Naftazone’s ability to influence platelet aggregation.
- Interactions with other antihypertensive agents could potentially cause minor, unpredictable fluctuations in vascular tone.
- Naftazone is a known substrate of the UGT1A6 enzyme; medications that strongly induce or inhibit this metabolic pathway could alter the concentration of Naftazone in the bloodstream.
Naftazone Food and Alcohol
- There are no strict food restrictions, though a high-fiber diet is strongly recommended for patients treating hemorrhoids.
- Excessive alcohol consumption should be avoided, as alcohol is a natural vasodilator that can worsen venous pooling in the legs and actively counteract the drug’s therapeutic benefits.
Naftazone: Missed Dose, Overdose & Storage
Consistent adherence ensures that the capillary walls remain continuously stabilized.
Missed Dose of Naftazone
If a dose is missed, patients should take it as soon as they remember on that same day. If it is already close to the time for the next scheduled dose, they should skip the missed tablet and resume their normal schedule. A double dose should never be taken to make up for a missed one.
Naftazone Overdose and Emergency
An overdose of Naftazone is not typically associated with immediate, life-threatening cardiovascular collapse, but it may cause significant gastrointestinal distress, nausea, and vomiting. If an overdose occurs, medical evaluation should be sought for symptomatic and supportive treatment.
How to Store Naftazone
Store the tablets at a controlled room temperature strictly inside their original packaging. The medication should be kept safely away from intense heat, excessive moisture, and entirely out of the reach of children.
Naftazone: Patient Management & Monitoring
Routine clinical oversight ensures that the venotonic agent is actively reducing the symptoms of chronic venous insufficiency without causing gastrointestinal intolerance.
Tests Before Starting Naftazone
- A basic clinical examination of the lower extremities to grade the severity of the varicose veins or edema.
- In severe cases, a venous Doppler ultrasound may be performed to definitively diagnose venous reflux and rule out deep vein thrombosis (DVT).
Monitoring During Naftazone Treatment
- Routine outpatient follow-ups to measure changes in ankle circumference and assess the reduction in localized leg swelling.
- Ongoing clinical evaluations of the patient’s symptomatic relief, particularly reductions in leg heaviness and pain.
Naftazone Do’s and Don’ts
- Do wear appropriately fitted medical compression stockings daily, as Naftazone is most effective when used in combination with physical compression therapy.
- Do elevate your legs when sitting or resting to naturally assist venous blood return to the heart.
- Don’t sit or stand in one position for prolonged periods, as immobility accelerates blood pooling in the lower legs.
- Don’t stop taking the medication prematurely if you don’t see results in the first few days; veno-active drugs often take several weeks to visibly reduce edema.
Frequently Asked Questions
What exactly does Naftazone do in the body?
Naftazone helps protect and strengthen the walls of your tiny blood vessels (capillaries). By preventing these vessels from stretching and leaking fluid, it reduces the leg swelling, pain, and heaviness caused by poor blood circulation.
Can Naftazone cure my varicose veins?
No, oral medications cannot permanently cure or reverse varicose veins that have already formed. However, Naftazone can significantly reduce the uncomfortable symptoms associated with them, such as aching and swelling.
Why is this medication not available in my country?
While it has been proven effective and is widely used in several European countries, it was never submitted for or did not undergo the specific regulatory trial requirements needed for approval by the primary regulatory agencies in countries like the United States.
How long do I have to take Naftazone before I feel better?
Veno-active medications typically take time to rebuild capillary strength. Most patients need to take the medication consistently for at least two to four weeks before noticing a significant reduction in leg swelling or hemorrhoidal pain.
Will Naftazone interact with my blood pressure pills?
It is generally safe to take with most blood pressure medications, but because it mildly affects blood vessels, you should always have your doctor review your full medication list to ensure there are no overlapping effects.
Can I just use compression socks instead of taking this pill?
Compression stockings are the gold standard for treating venous insufficiency. Naftazone is meant to be used alongside compression therapy, not as a replacement for it.
Is Naftazone a blood thinner?
No, Naftazone is not a true blood thinner (anticoagulant) like warfarin or Eliquis. It primarily stabilizes the vessel walls, though it does have a very mild effect on preventing blood platelets from clumping together.
References
- DrugBank – Naftazone Pharmacological Profile (DB13680)
- International Clinical Guidelines for Chronic Venous Disease Management
- National Cancer Institute (NCI) – Cardiology Treatment Protocols
Legal Disclaimer
The information provided is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider at Liv Hospital or your local clinic before starting or stopping any medication.


































